Therapeutic Advances in Gastroenterology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2023-11-10 ms5000001527012845 来自上海

一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！

117 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2025-02-25 ms1000000534985624 来自江苏省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：结直肠癌;综述;FMT
经验分享：2024.11.24投稿
2025.01.22给大修
2025.02.07修回
2025.2.24accept
实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept

16 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2024-10-06 zkfy 来自山东省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验

78 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2024-08-16 ms9000000883043898 来自湖南省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：不容易

65 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2024-04-11 烂医生来自北京

偏重的研究方向：炎症性肠病
经验分享：20天还是submitted，垃圾

111 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2021-12-27 学医的彭于晏

同一杂志社不同期刊如何转投（transfer）？

186 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2023-11-06 ms59932566 来自上海

审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。

168 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2023-11-02 MS54111233 来自上海

3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！

119 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2023-10-17 ms5000001464638126 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：一般

127 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2253517, encodeId=1546225351e16, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：结直肠癌;综述;FMT 经验分享：2024.11.24投稿 2025.01.22给大修 2025.02.07修回 2025.2.24accept 实际上一共花了三个月整，可以说是非常快了，投稿后under review后的状态没怎么关注，看了几眼知道送外审了。一共三个审稿人，给了大修，其中一个非常负责，另外两位简单提了一个意见，修回后审稿人1通过，审稿人2通过但是表示有细节要改，编辑直接给了accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59aa8720465, createdName=ms1000000534985624, createdTime=Tue Feb 25 11:55:50 CST 2025, time=2025-02-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=)]

2022-11-05 ms8000000798079608

偏重的研究方向：肿瘤
经验分享：请问大家这个杂志不收基础研究吗

158 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务